BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29311344)

  • 1. Ischemic Stroke Mandates Cross-Disciplinary Collaboration.
    Fisher M; Hill JA
    Circulation; 2018 Jan; 137(2):103-105. PubMed ID: 29311344
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of patent foramen ovale in atrial fibrillation patients with history of cerebral ischemia: a stand-alone additional risk?
    Zoppo F; Stabile G; Pappone A; Avella A; Pecora D; Corò L; Zingarini G; Verlato R; Castro A; Bertaglia E
    Int J Cardiol; 2014 Mar; 172(2):e290-1. PubMed ID: 24444485
    [No Abstract]   [Full Text] [Related]  

  • 3. Patent Foramen Ovale Closure: The Pendulum Swings.
    Hankey GJ; McQuillan BM
    Circulation; 2018 May; 137(19):1991-1993. PubMed ID: 29735585
    [No Abstract]   [Full Text] [Related]  

  • 4. Patent foramen ovale and stroke.
    Miranda B; Fonseca AC; Ferro JM
    J Neurol; 2018 Aug; 265(8):1943-1949. PubMed ID: 29680895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent Foramen Ovale: A Comprehensive Review.
    Teshome MK; Najib K; Nwagbara CC; Akinseye OA; Ibebuogu UN
    Curr Probl Cardiol; 2020 Feb; 45(2):100392. PubMed ID: 30327131
    [No Abstract]   [Full Text] [Related]  

  • 6. Closure of patent foramen ovale and "cryptogenic" stroke: What's new, what's next?
    Mas JL
    Arch Cardiovasc Dis; 2019 Mar; 112(3):145-149. PubMed ID: 30792077
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute treatment and secondary prophylaxis of ischemic stroke : An excellent example for personalized medicine].
    Wachter R; Gröschel K
    Internist (Berl); 2018 Mar; 59(3):241-251. PubMed ID: 29459990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
    Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Marco Bonifati D; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Tomelleri G; Spalloni A; Giorli E; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Piras V; Rasura M; Simone AM; Gamba M; Cerrato P; Zedde ML; Micieli G; Melis M; Massucco D; Guido D; De Giuli V; Bonaiti S; D'Amore C; La Starza S; Iacoviello L; Padovani A;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foreword.
    Curr Probl Cardiol; 2020 Feb; 45(2):100509. PubMed ID: 31902394
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCAI/ACC/HRS institutional and operator requirements for left atrial appendage occlusion.
    Kavinsky CJ; Kusumoto FM; Bavry AA; Bailey SR; Ellenbogen KA; Hess PL; Lustgarten DL; Moussa ID; Spies C
    Catheter Cardiovasc Interv; 2016 Feb; 87(3):351-62. PubMed ID: 26663263
    [No Abstract]   [Full Text] [Related]  

  • 12. Transcatheter closure of patent foramen ovale does not reduce the risk of recurrent ischemic stroke versus medical therapy alone: a meta-analysis of randomized controlled trials.
    Zhang B; Zhou J; Li H; Zhou M; Chen A; Zhao Q
    Int J Cardiol; 2013 Nov; 169(6):e106-8. PubMed ID: 24383119
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathophysiology and Risk of Atrial Fibrillation Detected after Ischemic Stroke (PARADISE): A Translational, Integrated, and Transdisciplinary Approach.
    Paquet M; Cerasuolo JO; Thorburn V; Fridman S; Alsubaie R; Lopes RD; Cipriano LE; Salamone P; Melling CWJ; Khan AR; Sedeño L; Fang J; Drangova M; Montero-Odasso M; Mandzia J; Khaw AV; Racosta JM; Paturel J; Samoilov L; Stirling D; Balint B; Jaremek V; Koschinsky ML; Boffa MB; Summers K; Ibañez A; Mrkobrada M; Saposnik G; Kimpinski K; Whitehead SN; Sposato LA
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):606-619. PubMed ID: 29141778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.
    Kasner SE; Thomassen L; Søndergaard L; Rhodes JF; Larsen CC; Jacobson J
    Int J Stroke; 2017 Dec; 12(9):998-1004. PubMed ID: 29090661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke of undetermined cause: workup and secondary prevention.
    Weimar C
    Curr Opin Neurol; 2016 Feb; 29(1):4-8. PubMed ID: 26641813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review.
    Saver JL; Mattle HP; Thaler D
    Stroke; 2018 Jun; 49(6):1541-1548. PubMed ID: 29760277
    [No Abstract]   [Full Text] [Related]  

  • 18. Further Promotion of Stroke Treatment with Delayed or Unknown Time of Onset but Smaller Benefit from Patent Foramen Ovale Closure than Pre-Applauded.
    Hennerici MG
    Cerebrovasc Dis; 2018; 45(5-6):I-II. PubMed ID: 30041190
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper: executive summary.
    Pristipino C; Anzola GP; Ballerini L; Bartorelli A; Cecconi M; Chessa M; Donti A; Gaspardone A; Neri G; Onorato E; Palareti G; Rakar S; Rigatelli G; Santoro G; Toni D; Ussia GP; Violini R; ; ; ; ; ; ; ;
    Catheter Cardiovasc Interv; 2013 Jul; 82(1):122-9. PubMed ID: 23788390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper.
    Pristipino C; Anzola GP; Ballerini L; Bartorelli A; Cecconi M; Chessa M; Donti A; Gaspardone A; Neri G; Onorato E; Palareti G; Rakar S; Rigatelli G; Santoro G; Toni D; Ussia GP; Violini R; ; ; ; ; ; ; ;
    Catheter Cardiovasc Interv; 2013 Jul; 82(1):E38-51. PubMed ID: 22936427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.